Cecil Pace-Asciak - Search Results

Year	Number of Results
2002	2
2003	4
2004	1
2005	5
2006	4
2007	3
2009	1
2010	1
2011	1
2012	1
2013	4
2014	2
2015	2
2018	1
2019	1
2020	1
2022	1
2024	0

1

Pace-Asciak CR. Pace-Asciak CR. Biochim Biophys Acta. 2015 Apr;1851(4):383-96. doi: 10.1016/j.bbalip.2014.09.007. Epub 2014 Sep 19. Biochim Biophys Acta. 2015. PMID: 25240838 Review.

2

The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPalpha isoform in transfected COS-7 cells.

Qiao N, Reynaud D, Demin P, Halushka PV, Pace-Asciak CR. Qiao N, et al. Among authors: pace asciak cr. J Pharmacol Exp Ther. 2003 Dec;307(3):1142-7. doi: 10.1124/jpet.103.056705. Epub 2003 Oct 14. J Pharmacol Exp Ther. 2003. PMID: 14560042

3

From the design to the clinical application of thromboxane modulators.

Dogné JM, Hanson J, de Leval X, Pratico D, Pace-Asciak CR, Drion P, Pirotte B, Ruan KH. Dogné JM, et al. Among authors: pace asciak cr. Curr Pharm Des. 2006;12(8):903-23. doi: 10.2174/138161206776055921. Curr Pharm Des. 2006. PMID: 16533159 Review.

4

Hepoxilins in cancer and inflammation--use of hepoxilin antagonists.

Pace-Asciak CR. Pace-Asciak CR. Cancer Metastasis Rev. 2011 Dec;30(3-4):493-506. doi: 10.1007/s10555-011-9307-y. Cancer Metastasis Rev. 2011. PMID: 22005952 Review.

5

The hepoxilins and some analogues: a review of their biology.

Pace-Asciak CR. Pace-Asciak CR. Br J Pharmacol. 2009 Oct;158(4):972-81. doi: 10.1111/j.1476-5381.2009.00168.x. Epub 2009 Apr 30. Br J Pharmacol. 2009. PMID: 19422397 Free PMC article. Review.

6

Novel eicosanoid pathways: the discovery of prostacyclin/6-keto prostaglandin F1alpha and the hepoxilins.

Pace-Asciak CR. Pace-Asciak CR. Mol Neurobiol. 2005 Aug;32(1):19-26. doi: 10.1385/mn:32:1:019. Mol Neurobiol. 2005. PMID: 16077180 Review.

7

Oxysterols in catfish skin secretions (Arius bilineatus, Val.) exhibit anti-cancer properties.

Al-Hassan JM, Afzal M, Oommen S, Liu YF, Pace-Asciak C. Al-Hassan JM, et al. Among authors: pace asciak c. Front Pharmacol. 2022 Oct 14;13:1001067. doi: 10.3389/fphar.2022.1001067. eCollection 2022. Front Pharmacol. 2022. PMID: 36313377 Free PMC article.

8

Furanoid F-Acid F6 Uniquely Induces NETosis Compared to C16 and C18 Fatty Acids in Human Neutrophils.

Khan MA, Pace-Asciak C, Al-Hassan JM, Afzal M, Liu YF, Oommen S, Paul BM, Nair D, Palaniyar N. Khan MA, et al. Among authors: pace asciak c. Biomolecules. 2018 Nov 13;8(4):144. doi: 10.3390/biom8040144. Biomolecules. 2018. PMID: 30428625 Free PMC article.

9

A lipid mediator hepoxilin A3 is a natural inducer of neutrophil extracellular traps in human neutrophils.

Douda DN, Grasemann H, Pace-Asciak C, Palaniyar N. Douda DN, et al. Among authors: pace asciak c. Mediators Inflamm. 2015;2015:520871. doi: 10.1155/2015/520871. Epub 2015 Feb 16. Mediators Inflamm. 2015. PMID: 25784781 Free PMC article.

10

Protective effects of dietary EPA and DHA on ischemia-reperfusion-induced intestinal stress.

Brahmbhatt V, Oliveira M, Briand M, Perrisseau G, Bastic Schmid V, Destaillats F, Pace-Asciak C, Benyacoub J, Bosco N. Brahmbhatt V, et al. Among authors: pace asciak c. J Nutr Biochem. 2013 Jan;24(1):104-11. doi: 10.1016/j.jnutbio.2012.02.014. Epub 2012 Jul 20. J Nutr Biochem. 2013. PMID: 22819560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

31 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year